한국어
Quantus

IBEX

IBEX · Nasdaq
$39.17-0.61%
2026-09-04 close

IBEX last closed at $39.17 (-0.61%) on 2026-09-04. Signals today: MA aligned. Listed on Nasdaq; price, financials and dividends update daily after market close.

Loading chart…
CloseMA20MA60MA120
Super Strong RS 84 · top 16%

New high + volume — the real recordrecord · not a prediction

Last 30 sessions
277 picks
Next-day win rate
44.2%
Avg next-day
-0.28%
vs market
-0.51%p

Every new-high-plus-volume pick we actually published (US market) — not this stock alone.

Signal history

DateSignal+20 trading days

A record, not a prediction.

How this is calculated

"·" means fewer than 20 trading days have passed since the event. Cup-and-handle entries are days our board actually showed the badge (archive grows daily since 2026-05-12); others are recomputed from price data.

Trade plan

Fill entry, stop, account size and risk percent to get a share count. The stop must sit below the entry.

A calculator · not advice or a guarantee

Financials & valuation at a glance

A+
Overall: 소프트웨어 14/371 · top 4%
Factor composite · relative position in sector

PER 14.31 · PBR 3.93 — own-history percentile 58/100 · 35/100

Open self-history band
PER58/100
PBR35/100

Factual information · not investment advice

Past reported results · not investment advice

More — deeper indicators

Financial safety

Reference indicatorAs of 2025
Safe zoneFinancial-metric reference signal
Altman Z'' zoneZ'' 4.05
Distress
Grey
Safe
The marker shows the current Z'' value within the displayed zones.
Altman Z''
4.05
Beneish M-Score
-2.23

No statistical flag

Sloan accrual
-3.22%

부실·조작 위험을 나타내는 사실 지표입니다. 투자 조언이 아니며, 검증 전이라 참고용입니다.

Factual information, not investment advice.

Why has this company moved this way?

Auditable observations with the original numeric evidence.

매출 성장 + 마진 확대 + FCF 양수

Positive

매출이 +9.8% 성장하면서 영업이익률이 7.8%에서 8.3%로 확대되었다. FCF도 양수를 유지하여 질적 성장이 확인된다.

Evidence

매출 YoY +9.8%영업이익률 7.8%→8.3%FCF 64

Factual information, not investment advice.

Earnings quality · Piotroski F-Score

5/9Moderate

Piotroski measures year-over-year financial improvement, not absolute quality.

Financial improvement score5/9

Profitability

  • Positive ROAPass
  • Positive OCFPass
  • Improving ΔROAPass
  • Accruals (OCF > net income)Pass

Leverage & liquidity

  • Lower debtNot passed
  • Higher current ratioNot passed
  • No new sharesNot passed

Efficiency

  • Higher gross marginNot passed
  • Higher asset turnoverPass

Calculation note: F7(신주)은 equity/asset 유지로 근사

Already-stable companies may score lower when year-over-year improvement is limited.

Factual information, not investment advice.

Forensic signals

Anomaly and structural signals observed in the financial statements.

Cash conversion cycleWarning

현금전환주기(CCC) 5기 연속 확대 — 운전자본 경색·현금 회수 지연 주의. 통계적 정황 신호이며 회계부정 단정이 아닙니다.

Factual information, not investment advice.

Industry structure

USAs of 2026-09-05

소프트웨어

This stock is in 소프트웨어: revenue rank 175 of 350, share 0%.

175 / 3500%revenue share

Who dominates this industry?

  1. 1Alphabet Class A19.4%
  2. 2Microsoft15.6%
  3. 3Meta Platforms Class A9.1%
  4. 4Accenture Class A3.9%
  5. 5International Business Machines3.5%
  6. 6IBEX0%

Concentration

DistributedCR3 44.2%
HHI 783350 revenue members

HHI and CR3 are separate industrial-organization facts; they are not the polarization verdict.

Polarization

Winner-take-all deepeningConsistent

Polarization measures industry gaps and structure, not valuation, forecast, or investment advice.

Margin lens

IQR%p
26.71
Direction
확대
Level
넓음
Years
24

Value lens

P90/P10
27
Median P/B
4.05
Level
넓음
n
303

Survivorship note: 현재 산업 멤버십을 과거 연도에 소급 적용 — 과거 진입·퇴출 기업 미반영(복원 불가)

Factual information, not investment advice.

Risk sensitivity — adverse assumptions

Metric changes under stated assumptions; not a forecast or investment advice.

Base metrics

Operating margin
8.3%
Interest coverage
28.5x
Return on equity (ROE)
27.4%

Operating margin −5pp

Severe margin pressure
Interest coverageBase 28.5x adverse case 11.4x
Return on equity (ROE)Base 27.4% adverse case 12.7%

Revenue −15%

Tolerable
Interest coverageBase 28.5x adverse case 24.2x
Return on equity (ROE)Base 27.4% adverse case 28.3%

Interest rate +2pp

Tolerable
Interest coverageBase 28.5x adverse case 10.6x
Return on equity (ROE)Base 27.4% adverse case 31.4%

Interest coverage limit

Current margin 8.1pp

Interest coverage limit at an operating margin of 0.3%

Interest expense coverage threshold

Connections

AI-extracted related companies · for reference

Same theme
Healthcare ServicesBusiness Process Outsourcing
🔗 See in the full market map →

Recent filings

Filings for overseas stocks are on the way. For now we cover Korean stocks only.

About IBEX
What technical signals does IBEX (IBEX) have?
IBEX current technical signals: MA alignment (score 0.75).
Is IBEX a cup-and-handle pattern?
No. IBEX has no valid cup-and-handle signal right now.
What are IBEX's financials and valuation?
IBEX's income statement, balance sheet and cash flow are free for the most recent 8 years; the full history is on Pro. PER/PBR, dividend yield and sector valuation bands are free.

Like these rules? Backtest them.

Run this signal on this ticker in the free backtest builder — same window, no install.

Backtest this rule ↗

Quantus Signal · live data · not investment advice · Privacy Policy